Micro Medical Solutions

Executive Summary

Micro Medical Solutions is a San Diego-based private medical device company founded in 2015, focused on developing minimally invasive tools for the endovascular treatment of Critical Limb Ischemia (CLI). The company targets below-the-knee (BTK) interventions, specifically addressing long lesions and chronic total occlusions (CTOs) that often lead to preventable amputations. With an aging population and rising prevalence of peripheral artery disease, the demand for effective BTK solutions is substantial. Micro Medical Solutions aims to fill this gap with proprietary technologies designed to improve procedural outcomes and limb salvage rates. The company's lead product candidate leverages advanced catheter-based approaches to navigate complex BTK anatomy, potentially offering advantages over existing options in terms of safety and efficacy. While still in the developmental phase, the company's technology has generated interest from vascular specialists. If successful, the platform could become a key tool in the CLI treatment paradigm, reducing amputation rates and healthcare costs. The company operates in a competitive landscape but benefits from a focused strategy on an underserved high-risk patient population.

Upcoming Catalysts (preview)

• Q3 2026First-in-human or pivotal trial results65% success
• Q2 2026Series A or B financing round70% success
• Q4 2026FDA breakthrough device designation or 510(k) submission55% success